Implants

Conformis Announces First Procedure Performed Using New Actera™ Hip System

First Actera™ procedure underscores company’s ongoing commitment to advancing joint replacement technology by leveraging its data-driven approach and surgical planning expertiseBILLERICA,…

2 years ago

Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing

LEWISVILLE, Texas and CARLSBAD, Calif., Nov. 18, 2022 (GLOBE NEWSWIRE) -- Orthofix (NASDAQ: OFIX), a global medical device company with…

2 years ago

Sernova Announces First Two Patients Implanted with Cell Pouch™ in the Second Cohort of its US Phase 1/2 Clinical Trial for Type 1 Diabetes

Company’s recent recruitment strategy change has resulted in an unprecedented level of inquiries regarding potential study participationTransplantation of islets into…

2 years ago

Conformis Announces Full Commercial Launch of Imprint™

Conformis’ Imprint™ knee system introduces the new “Made-to-Measure” product category option for Total Knee Arthroplasty (TKA)BILLERICA, Mass., Nov. 17, 2022…

2 years ago

ContraFect Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Continued execution to advance exebacase and CF-370 into new clinical studiesYONKERS, N.Y., Nov. 14, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation…

2 years ago

Accelus Announces FDA 510(k) Clearance for Remi Robotic Navigation System Software Update that Allows Image Acquisition with all Major 3D Imaging Systems

Remi Robotic Navigation System Accelus Announces FDA 510(k) Clearance for Remi Robotic Navigation System Software Update that Allows Image Acquisition…

2 years ago

Eurospine Congress a very successful meeting with spine professionals for Spineway

Press Release         Ecully, 28th of October, 2022 – 8:45 am Remarkable participation at 2022 Eurospine congress in Milan Spineway and…

2 years ago

LeMaitre Q3 2022 Financial Results

BURLINGTON, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported…

2 years ago

TELA Bio Announces Publication of 24-Month BRAVO Study Results Demonstrating Benefits of OviTex® Reinforced Tissue Matrix in Hernia Repair

Study results show a low 2.6% recurrence rate and clinically meaningful improvement in patient quality of lifeMALVERN, Pa., Oct. 26,…

2 years ago